Aethlon medical receives ethics board approval to add second site to its ongoing clinical trial of its hemopurifier® to treat severe covid-19 in india

San diego , may 22, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced that it has received ethics review board (erb) approval from the maulana azad medical college (mamc), for a second site for its ongoing clinical trial of aethlon's hemopurifier® to treat severe covid-19 in india. mamc was established in 1958 and is located in new delhi, india.
AEMD Ratings Summary
AEMD Quant Ranking